Canine Vaccine D292

Nobivac Canine 1-DAPPv

• Transfer contents of the sterile diluent vial to the Nobivac Canine 1-DAPPv vial
• Gently mix until dissolved
• Inject one dose (1mL) subcutaneously or intramuscularly
• The initial dose may be given at 6 weeks of age or older
• Repeat dose 2 to 4 weeks later
• Two doses are required for primary immunization

Recommended for vaccination against canine distemper, canine hepatitis, adenovirus cough (kennel cough), parainfluenza, and parvovirus. The parvovirus portion is modified live canine cell origin. Contains no leptospirosis. Canine adenovirus-2 (CAV-2) helps provide protection against both canine infectious hepatitis and tracheobronchitis (kennel cough). Given subcutaneously or intramuscularly.